Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system to address diseases including glaucoma and metabolic conditions, will present an overview of its...
Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, initially through modulation of the CB1 receptor, to address diseases including glaucoma and...
Skye Bioscience, Inc. , a pharmaceutical company developing drugs targeting the endocannabinoid system, initially through modulation of the CB1 receptor, to address diseases including glaucoma and...
Skye Bioscience, Inc. , a pharmaceutical company developing proprietary medicines that modulate the endocannabinoid system to treat diseases with inflammatory, fibrotic, and metabolic processes, with...
Shares of Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $2.01 and last traded at $2.45, with a volume of 2497 shares changing hands. The stock had previously closed at $2.35. Skye Bioscience Stock Performance The firm’s fifty day […]